EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Detection Rate of PSMA PET Using Different Ligands in Men with Biochemical Recurrent Prostate Cancer Following Radical Treatment: A Systematic Review and Meta-analysis of Prospective Studies

Qiushuo Wu, Anthony Bates, Prasad Guntur, Shamim Ahmed Shamim, Ghulam Nabi

Academic Radiology · 2024

DOI: 10.1016/j.acra.2023.08.044 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Academic Radiology, 2024. Verfasst von Qiushuo Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medical Engineering and Technology, University of Dundee, Scotland, UK. Electronic address: 2402131@dundee.ac.uk. Hauptthemen laut MEDLINE: Prostate-Specific Antigen, Prostatic Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite the acknowledged diagnostic detection rate of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging in prostate cancer, little is known about the quality of evidence, particularly focusing on prospective studies. Most systematic reviews are based on retrospective reports. RATIONALE AND OBJECTIVES: To conduct systematic review and meta-analysis of prospective studies reporting the diagnostic detection rate of PSMA PET (computed tomography (CT) and MR) for the detection of biochemically recurrent metastatic prostate cancer. MATERIALS AND METHODS: We systematically searched PubMed, MEDLINE, Embase, and Scopus, from database until March 1, 2023 for randomized controlled trials and prospective studies using PSMA PET imaging in prostate cancer. The primary endpoint was to assess diagnostic detection rate of PSMA PET imaging in the detection of recurrent prostate cancer in men with biochemical relapse following radical treatment. We calculated the pooled overall diagnostic detection rate with 95% CI using a random-effects model and assessed the heterogeneity between the studies including risk of biases estimation. RESULTS: A total of 6800 patients from 32 articles were included in this study. The overall detection rate of PSMA PET for prostate cancer was 0.67 (95% CI, 0.63, 0.71). For histologically confirmed lymph nodes, the PPV from 13 prospective studies containing 1496 patients was 0.96 (95% CI, 0.93, 0.99). We performed a subgroup analysis of PSMA PET detection rates according to categorically grouped Prostate Specific Antigen (PSA) values of 0-0.5, 0.5-1.0, 1.0-2.0, and >2.0 ng/ml and obtained detection rates of 0.44, 0.63, 0.82, and 0.94, respectively. The detection rate of 18F PSMA was better in men with a PSA between 1 ng/ml and 2 ng/ml in comparison to 68Ga PSMA (0.91 with 95% CI 0.81-0.99 vs. 0.79 with 95% CI 0.73, 0.85). CONCLUSION: PSMA PET imaging provides a good detection rate for the metastatic recurrence of prostate cancer in men with biochemical relapse following radical treatment. The detection rate improves significantly above a serum PSA value of 1 ng/ml. The diagnostic detection rate of 18F-PSMA is best at PSA values between 1 and 2 ng/ml, in comparison to 68Ga PSMA. This conclusion is heavily biased, further research needs to focus on better methodology to minimize the risk of biases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostate-Specific AntigenProstatic NeoplasmsMaleHumansProspective StudiesRetrospective StudiesNeoplasm Recurrence, LocalPositron-Emission TomographyPositron Emission Tomography Computed TomographyRecurrence

Stichwörter der Autor:innen

Biochemical recurrencePETPSAPSMAProstate

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Centre for Medical Engineering and Technology, University of Dundee, Scotland, UK. Electronic address: 2402131@dundee.ac.uk.
  • Centre for Medical Engineering and Technology, University of Dundee, Scotland, UK.
  • NHS Tayside, Dundee, Scotland, UK.
  • Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Centre for Medical Engineering and Technology, University of Dundee, Scotland, UK. Electronic address: GNabi@dundee.ac.uk.

Zitieren

APA

Wu, Q., Bates, A., Guntur, P., Shamim, S. A., & Nabi, G. (2024). Detection Rate of PSMA PET Using Different Ligands in Men with Biochemical Recurrent Prostate Cancer Following Radical Treatment: A Systematic Review and Meta-analysis of Prospective Studies. Academic Radiology. https://doi.org/10.1016/j.acra.2023.08.044

Vancouver

Wu Q, Bates A, Guntur P, Shamim SA, Nabi G. Detection Rate of PSMA PET Using Different Ligands in Men with Biochemical Recurrent Prostate Cancer Following Radical Treatment: A Systematic Review and Meta-analysis of Prospective Studies. Academic Radiology. 2024. doi:10.1016/j.acra.2023.08.044

BibTeX
@article{Wu2024,
  author = {Wu, Qiushuo and Bates, Anthony and Guntur, Prasad and Shamim, Shamim Ahmed and Nabi, Ghulam},
  title = {Detection Rate of PSMA PET Using Different Ligands in Men with Biochemical Recurrent Prostate Cancer Following Radical Treatment: A Systematic Review and Meta-analysis of Prospective Studies},
  journal = {Academic Radiology},
  year = {2024},
  doi = {10.1016/j.acra.2023.08.044}
}
Kostenlos starten →